Horizon Investments, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Horizon Investments, LLC

$4.32 Billion
Q3 2024

A detailed history of Horizon Investments, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Horizon Investments, LLC holds 1,552 shares of REGN stock, worth $1.04 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,552

Previous 1,651 6.0%

Holding current value

$1.04 Million

Previous $1.74 Million 5.99%

% of portfolio

0.04%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1024.09 - $1201.76 $101,384 - $118,974	-99 Reduced 6.0%	1,552 $1.63 Million
Q2 2024 Aug 09, 2024	BUY	$883.2 - $1071.19 $6,182 - $7,498	7 Added 0.43%	1,651 $1.74 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $32,496 - $35,760	36 Added 2.24%	1,644 $1.58 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $620,144 - $705,360	800 Added 99.01%	1,608 $1.41 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $15,926 - $19,420	23 Added 2.93%	808 $664,000
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $37,801 - $44,838	-54 Reduced 6.44%	785 $564,000
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $392,642 - $477,161	-577 Reduced 40.75%	839 $689,000
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $1.15 Million - $1.25 Million	-1,634 Reduced 53.57%	1,416 $1.02 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $514,851 - $649,715	897 Added 41.66%	3,050 $2.1 Million
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $1.24 Million - $1.67 Million	-2,255 Reduced 51.16%	2,153 $1.27 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $471,930 - $553,854	793 Added 21.94%	4,408 $3.08 Million
Q4 2021 Feb 15, 2022	BUY	$543.48 - $670.97 $697,284 - $860,854	1,283 Added 55.02%	3,615 $2.28 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $355,898 - $422,195	620 Added 36.21%	2,332 $1.41 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $269,496 - $318,367	-570 Reduced 24.98%	1,712 $956,000
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $1.02 Million - $1.25 Million	2,282 New	2,282 $1.08 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $1.25 Million - $1.59 Million	-2,613 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $1.49 Million - $1.8 Million	-2,735 Reduced 51.14%	2,613 $1.46 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $2.12 Million - $2.76 Million	4,290 Added 405.48%	5,348 $3.34 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $38,324 - $56,365	114 Added 12.08%	1,058 $517,000
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $258,778 - $355,425	944 New	944 $354,000
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $192,789 - $224,464	-705 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $60,818 - $84,208	203 Added 40.44%	705 $221,000
Q1 2019 May 16, 2019	BUY	$372.08 - $439.57 $186,784 - $220,664	502 New	502 $206,000

Others Institutions Holding REGN

# of Institutions

1,500

Shares Held

83M

Call Options Held

1.22M

Put Options Held

1.5M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Investments, LLC with notifications on news.

Account

Horizon Investments, LLC Regeneron Pharmaceuticals, Inc. Transaction History